A detailed history of Larson Financial Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Larson Financial Group LLC holds 12,344 shares of ABT stock, worth $1.59 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
12,344
Previous 11,120 11.01%
Holding current value
$1.59 Million
Previous $1.16 Million 21.82%
% of portfolio
0.08%
Previous 0.08%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $122,485 - $144,591
1,224 Added 11.01%
12,344 $1.41 Million
Q2 2024

Aug 02, 2024

BUY
$100.73 - $112.44 $518,860 - $579,178
5,151 Added 86.3%
11,120 $1.16 Million
Q1 2024

May 03, 2024

BUY
$109.52 - $120.96 $474,112 - $523,635
4,329 Added 263.96%
5,969 $678,000
Q4 2023

Feb 01, 2024

SELL
$90.19 - $110.4 $40,495 - $49,569
-449 Reduced 21.49%
1,640 $180,000
Q3 2023

Nov 03, 2023

SELL
$95.53 - $114.62 $49,102 - $58,914
-514 Reduced 19.75%
2,089 $202,000
Q2 2023

Aug 03, 2023

SELL
$100.78 - $112.29 $29,830 - $33,237
-296 Reduced 10.21%
2,603 $283,000
Q1 2023

May 04, 2023

SELL
$96.86 - $114.01 $224,327 - $264,047
-2,316 Reduced 44.41%
2,899 $293,000
Q4 2022

Feb 03, 2023

SELL
$95.06 - $111.52 $24,905 - $29,218
-262 Reduced 4.78%
5,215 $572,000
Q3 2022

Nov 03, 2022

BUY
$96.76 - $112.03 $360,140 - $416,975
3,722 Added 212.08%
5,477 $530,000
Q2 2022

Aug 04, 2022

BUY
$102.07 - $123.37 $10,513 - $12,707
103 Added 6.23%
1,755 $191,000
Q1 2022

May 05, 2022

BUY
$114.02 - $139.04 $114 - $139
1 Added 0.06%
1,652 $196,000
Q4 2021

Feb 03, 2022

BUY
$115.53 - $141.46 $155,272 - $190,122
1,344 Added 437.79%
1,651 $232,000
Q3 2021

Nov 04, 2021

SELL
$116.66 - $129.06 $7,232 - $8,001
-62 Reduced 16.8%
307 $36,000
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $740 - $871
-7 Reduced 1.86%
369 $43,000
Q1 2021

May 06, 2021

SELL
$108.84 - $128.23 $8,054 - $9,489
-74 Reduced 16.44%
376 $45,000
Q4 2020

Jan 14, 2021

SELL
$105.0 - $114.42 $1,575 - $1,716
-15 Reduced 3.23%
450 $49,000
Q3 2020

Oct 08, 2020

SELL
$91.64 - $111.29 $60,757 - $73,785
-663 Reduced 58.78%
465 $51,000
Q2 2020

Jul 10, 2020

BUY
$76.57 - $98.0 $59,494 - $76,146
777 Added 221.37%
1,128 $103,000
Q1 2020

Apr 09, 2020

BUY
$62.82 - $91.86 $17,401 - $25,445
277 Added 374.32%
351 $28,000
Q4 2019

Jan 10, 2020

SELL
$78.51 - $87.4 $20,962 - $23,335
-267 Reduced 78.3%
74 $6,000
Q3 2019

Oct 11, 2019

BUY
$81.84 - $88.74 $5,155 - $5,590
63 Added 22.66%
341 $29,000
Q2 2019

Jul 16, 2019

BUY
$72.88 - $85.0 $72 - $85
1 Added 0.36%
278 $23,000
Q1 2019

Apr 05, 2019

BUY
$66.22 - $80.06 $595 - $720
9 Added 3.36%
277 $22,000
Q4 2018

Feb 07, 2019

BUY
$65.56 - $74.27 $17,570 - $19,904
268 New
268 $19,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.